pharmaphorum

JANUARY 24, 2023

Survival of the fittest: Biotech reset “Horrible” and “carnage” were how some described the early 2022 environment for biotech financing, as funding fell significantly below the highs of 2020 and 2021, and IPOs all but dried up. Europe still has a long-term energy crisis, even if near-term acute impacts have been avoided.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

NOVEMBER 4, 2022

The Covid-19 pandemic , Brexit , the Russian war against Ukraine , and a subsequent global inflation crisis have caused a difficult economic climate in the UK for any PM to take on. You want to create an environment that replicates why Silicon Valley was successful in the 80s and 90s.

Documentation 93

Documentation Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

AUGUST 16, 2022

In this article, Ben Hargreaves looks at how companies have reacted to an unfavourable economic climate and what that could mean for the long-term growth of the industry. The idea 12 months ago that the health and wellness app space could soon be facing a crisis would have seemed highly pessimistic. Counting the cost.

52

52

The Guardian - Pharmaceutical Industry

JULY 18, 2023

While the Covid-19 pandemic led to the loss of 7 million lives globally, Soriot says that the climate crisis and pollution “cost us 7 million to 9 million lives every year”. Continue reading.

Vaccines 69

Vaccines 69

European Pharmaceutical Review

SEPTEMBER 14, 2023

As a result of the economic uncertainty, 75 percent of life sciences company executives have experienced negative impacts on their business in the current macroeconomic climate. The drug shortage crisis in the United States: causes, impact, and management strategies. 1 We can only learn from the past and try not to repeat history.

Communication 86

Communication Patient Care 86

Hospital Pharmacy Europe

MAY 9, 2024

Here, Gerry Hughes reports on the key themes and highlights from the congress such as AI, climate change and AMR. As in previous years, antimicrobial resistance (AMR) was a topic of concern among speakers and delegates alike, with issues such as artificial intelligence (AI) and climate change also high on the congress agenda.

Hospitals 52

Hospitals Communication Documentation Clinic Management 52

ISPE

MARCH 6, 2023

Beattie, CEng Michael Hell, PhD Sarah Mandlebaum Ester Lovsin Barle, DVM, MSc, PhD, MScTox 1 March 2023 The scientific community accepts that greenhouse gas (GHG) emissions cause global warming and climate change. 1 Intergovernmental Panel on Climate Change (IPCC). C global warming scenario.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

SEPTEMBER 12, 2022

This is the PIC/S Guide to Good Practices for Data Management and Integrity in Regulated GMP Environments. But if you become complacent, obviously you may be in a reactive or crisis mode later, even with a robotic isolator. If designed and controlled right, it will lead to better, sustainable assurance of supply and quality every day.

FDA 52

FDA Documentation Communication 52

Pharmaceutical Technology

MARCH 22, 2023

You also need to create an attractive climate for the people that you want to have for these kinds of initiatives to want to locate and be present in the European Union.” GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JANUARY 20, 2023

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution. Additionally, climate change has a direct impact on population health – and in turn pharmaceutical demand.

Pharmaceutical Companies 142

Pharmaceutical Companies Pharmaceutical Companies Packaging Communication 142